ISOThrive
Microbiome Therapeutics
MANASSAS, United States · Founded 2013
- Headquarters
- MANASSAS
- Employees
- 1–10
- Founded
- 2013
- Business Model
- B2B
- Website
- pharma.isothrive.com
About
We treat chronic disease caused by microbiome dysbiosis. Our first indication affects 1/3 of the US population and presents a $16B annual market opportunity. Beyond that, we have disrupted drug discovery with a shorter timeline to market, faster investment return and relatively small up-front investment. With our Lightning Rapid Carbohydrate Drug Discovery Platform, ISOThrive has a pipeline of novel MIMOs targeting a range of upper and lower GI conditions.
Summary
ISOThrive is a Biotech company based in MANASSAS, United States, founded in 2013.
Tech & App Stack
1 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company